DaVita Inc. (NYSE:DVA) Stock Position Increased by CIBC Asset Management Inc

CIBC Asset Management Inc lifted its position in DaVita Inc. (NYSE:DVA) by 1.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,730 shares of the company’s stock after buying an additional 109 shares during the period. CIBC Asset Management Inc’s holdings in DaVita were worth $1,156,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. MML Investors Services LLC raised its stake in shares of DaVita by 1.3% in the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock worth $869,000 after buying an additional 68 shares in the last quarter. Exchange Traded Concepts LLC raised its stake in shares of DaVita by 8.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock worth $133,000 after buying an additional 68 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of DaVita by 1.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company’s stock worth $776,000 after buying an additional 70 shares in the last quarter. Impact Partnership Wealth LLC raised its stake in shares of DaVita by 3.7% in the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock worth $290,000 after buying an additional 70 shares in the last quarter. Finally, Contravisory Investment Management Inc. raised its stake in shares of DaVita by 1.2% in the 4th quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock worth $910,000 after buying an additional 73 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

Shares of NYSE DVA opened at $142.33 on Friday. DaVita Inc. has a 52-week low of $120.78 and a 52-week high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The stock has a market capitalization of $11.39 billion, a price-to-earnings ratio of 13.25, a PEG ratio of 1.07 and a beta of 0.94. The stock’s fifty day simple moving average is $161.03 and its 200 day simple moving average is $158.00.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, sell-side analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

DVA has been the topic of a number of research reports. Barclays boosted their price objective on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $162.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.